Scale of Alopecia Areata Distress (SAAD)

Applications

• Assess the psychosocial benefits/impacts of emerging and existing treatments on patients' lives.
• Psychologists treating patients could likewlise use the SAAD to assess where patients are most impacted, to subsequently direct treatment focus, and measure patient progress.

Technology Overview

Researchers at University of Minnesota in collaboration with researchers at University of Wisconsin, Stout have developed SAAD. SAAD is a tool (e.g., scale) for assessing the psychosocial impact of Alopecia Areata/Totalis/Universalis on patients' lifes developed at the University of Minnesota. The tool consists of a set of survey items. The original version consisted of 122 items; the revised version consists of 41 items. Unlike other existing scales, SAAD is focused only on psychosocial impacts and covers 7 domains of impacts demonstrated as important to patients, and thus is a longer assessment tool.

Phase of Development

Desired Partnerships

• License
• Sponsored research
• Co-development

Please contact our office to share your business’ needs and learn more.

Researchers

• Maria K. Hordinsky, MD Professor, Department of Dermatology
• Kristina Gorbatenko-Roth, Professor, Department of Psychology, University of Wisconsin, Stout